HK Stock MarketDetailed Quotes

06855 ASCENTAGE-B

Watchlist
  • 17.760
  • -4.190-19.09%
Market Closed Mar 28 16:08 CST
5.15BMarket Cap-5045P/E (TTM)

About ASCENTAGE-B Company

Ascorbic Pharma is a globally focused clinical-stage biotechnology company dedicated to developing novel therapies for cancer, the hepatitis B virus, and age-related diseases. The company focuses on developing treatments that inhibit protein-protein interactions to restore apoptosis or programmed cell death. Ascorbic Pharma has established new products including eight drug candidates, including novel, highly effective Bcl-2/Bcl-XL inhibitors, candidates targeting the IAP and MDM2-p53 pathways, and next-generation tyrosine kinase inhibitors. The company has conducted 28 phase I/II clinical trials to evaluate eight products from the US, Australia, and China to develop potential treatments as single drugs or combination drugs.

Company Profile

Symbol06855
Company NameASCENTAGE-B
ISINKYG0519B1023
Listing Date10/28/2019
Issue Price34.20
Shares Offered12.18M share
Founded11/17/2017
RegistrationCayman Islands
ChairmanDajun Yang
SecretaryZhangqi Wang
Audit InstitutionErnst & Young
Company CategoryOther
Registered OfficeWalkers Corporate Limited Cayman Corporate Centre 27 Hospital Road George Town Grand Cayman KY1-9008 Cayman Islands
Head Office and Principal Place of BusinessUnit B, 17th floor, United Centre, 95 Queensway, Admiralty, Hong Kong
Fiscal Year Ends12-31
Employees583
MarketHong Kong motherboard
Phone(86)51285557777
EmailIR@ascentage.com
Business Yasheng Pharmaceutical Group is an investment holding company mainly engaged in developing innovative microtherapeutics for cancer, hepatitis B virus and several age-related diseases. The company has a self-developed drug design platform targeting protein-protein interactions. The company's main products include next-generation kinase inhibitor HQP1351, apoptosis targeting drugs APG-1252, APG2575, APG-115, etc. The company operates in domestic markets and overseas markets such as the US.

Company Executives

  • Name
  • Position
  • Salary
  • Dajun Yang
  • Authorized Representative,Remuneration Committee Member,CEO,Executive Director,Chairman of the Board,Nomination Committee Chairman
  • 4.02M
  • Shaomeng Wang
  • Chairman of the Scientific Advisory Board,Non-Executive Director
  • 1.11M
  • Dazhong Lv
  • Non-Executive Director,Audit Committee Member
  • 59.00K
  • Changqing Ye
  • Independent Non-Executive Director,Audit Committee Chairman,Nomination Committee Member
  • 567.00K
  • Zheng Yin
  • Audit Committee Member,Remuneration Committee Chairman,Independent Non-Executive Director
  • 567.00K
  • Wei Ren
  • Independent Non-Executive Director,Remuneration Committee Member,Nomination Committee Member
  • 567.00K
  • David Sidransky
  • Independent Non-Executive Director
  • 559.00K
  • Yifan Di
  • Chief Medical Officer
  • --
  • Raymond Jeffrey KMETZ
  • Chief Commercial Officer
  • --
  • Thomas Joseph KNAPP
  • General Counsel,Senior VP
  • --
  • Yiqing Chen
  • CFO
  • --
  • Gang Zhu
  • Chief Commercial Operations Officer
  • --
  • Zhangqi Wang
  • Authorized Representative,Company Secretary
  • --

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
HK
Overall
Symbol
Latest Price
%Chg